Abstract. Some novel derivatives of 2-(9H-Purin-6-ylsulfanyl)acetohydrazide were synthesized by reacting it with respective aldehydes in ethanol. The antithyroid effect of these compounds was ascertained in vitro by studying their complexation with iodine spectrophotometrically. In vivo, the hormonal as well as histological variations in male Wistar rats demonstrated significant antithyroid potential (p ≤ 0.05) of these compounds. Key words: Hyperthyroidism, Antithyroid activity, Hydrazides, In vitro activity, In vivo Activity.
Introduction
Hyperthyroidism is a condition characterized by over production of the thyroid hormones. It directly or indirectly disturbs the whole body including mental and physical growth [1] . The available treatments for hyperactive thyroid are thyroidechtomy (surgical removal of a part or whole gland), radioactive iodine therapy or use of antithyroid drugs. The former two modes though provide a permanent treatment but have serious set backs like perpetual hypothyroidism as well as complications arising out of surgery like tracheal suppressing etc. Moreover, there are certain hyperthyroid conditions which are not permanent and do not need surgery or radio iodine therapy; the use of antithyroid drugs becomes the only choice in such conditions [2] . On the other hand, there is a scarcity of drugs in this particular area. The widely used synthetic antithyroid agents (SATs) like propylthiouracil, methimazole and carbimazole belong to sulfonamide group and have serious side effects [3] . Keeping in view the scarcity and side effects of the existing drugs, many compounds were evaluated and some were reported to possess recognizable antithyroid activity [4] . It has been observed that compounds capable of making stable charge transfer complex with iodine and having formation constant (K c ) values ≥100 L mol -1 generally exhibit antithyroid effects in vivo [5] . Keeping in view the ability of heterocyclic compounds, especially purines, to complex with iodine [6] , certain purine derivatives were evaluated for potential antithyroid effects and significant antithyroid activity was observed in vivo [7] . 6-Mercaptopurine (9H-purine-6-thiol) and its alkyl derivatives were also found to inhibit thyroid activity via complexation with iodine [8] . 6-(Benzylsulfanyl)-9H-Purin was found most active amongst the series, probably because of the presence of conjugation. So, we planned to synthesize a series of compounds with aromatic substituents to get enhanced activity. At the same time, biological activity of hydrazides and acetohydrazides has also been reported [9] . Therefore, it was planned to synthesize N'-[substituted alkylphenylmethylidene]-2-(9H-purin-6-ylsulfanyl)acetohydrazides (3-11) as prospective SATs with 6-mercaptopurine as a starting material. The compounds (3) (4) (5) (6) (7) (8) (9) (10) (11) are expected to be novel as they are not found to be reported in the literature elsewhere. The Sulfanyl group, which is thought to be a cause of toxic side effects of many synthetic drugs, has been blocked in these compounds [10] . Therefore, it can be fairly assumed that these compounds would be less toxic. The antithyroid activity of purified compounds was evaluated in vitro by studying their complexation with iodine spectrophotometrically and in vivo in male Wistar rats.
Results and Discussion

Synthesis
Ethyl (9H-purin-6-ylsulfanyl)acetate (1) and 2-(9H-Purin-6-ylsulfanyl)acetohydrazide (2) were synthesized by using both conventional and microwave assisted reactions. The use of microwave oven not only substantially reduced the reaction time but also resulted in higher yields and purer products. N'-[substituted phenylmethylidene]-2-(9H-purin-6-ylsulfanyl)acet ohydrazide (3) (4) (5) (6) (7) (8) (9) (10) (11) were synthesized by the reaction of 2 with substituted aryl aldehydes in ethanol (Scheme 1).
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Assessment of antithyroid activity
In Vitro
The solutions of pure compounds in DMSO have absorption maxima in UV region and spectral data indicate the complex formation mostly at 265-70 nm (Table 1 ). All the compounds except 2, demonstrated 1:1 charge transfer (CT) complexation with iodine. However, 2 also exhibited complex formation near 315 nm. The compounds exhibited K c values well above 100 L mol -1 , which indicate their good antithyroid potential.
It is observed that the stability of the complex with iodine not only depends upon the substituents but also on their location in the ring like the presence of a nitro group at meta position (4) resulted in more stable complex as compared to ortho (5) and para (3) positions.
In vivo
In vivo the blood assays showed decrease of varying degree in FT 3 and FT 4 levels with a corresponding increase in Thyroid-stimulating hormone (TSH) concentrations for the animals treated with the compounds (1-11) as compared to control and vehicle control ( Table 2 ). The hormonal variations were quite significant (p ≤ 0.05).
The antithyroid potential of 3-11 was found to be weaker than methimazole, which was introduced as "positive control" in the study yet some compounds like 3, 4 and 8 exhibited comparable antithyroid effects.
The Line-Column Plot between the percentage hormonal variations versus K c values revealed a positive correlation between the formation constants and antithyroid activity in vivo (Fig. 1) .
The histological studies also revealed the antithyroid effects of the compounds as the follicular epithelia in the treated animals were found to be cylindrical with larger nuclei rather than to be of cuboidal shape like in control animals (Fig. 2 ).
Moderate to severe colloid depletion and follicular hyperplasia and hypertrophy were also observed in the treated animals as compared to the control groups.
Thyroid body index (TBI) is a useful parameter defined as weight of clean thyroid tissues (mg) per 100 g of final body weight of the animal. These indices for the treated animals were found quite higher than the controls, which show the increased glandular activity. In fact, the compounds created artificial iodine deficiency and retarded the biosynthesis of thyroid hor- mones. In response to the decreased hormonal concentrations in the blood, the pituitary released more quantities of TSH thus directing the gland to produce more hormones. The gland responded accordingly by increasing the number (hypertrophy) and size of the follicular cells (hyperplasia) and consuming the colloid storage to produce more hormones. The cylindrical shape as compared to the cuboidal allows more cells per unit volume of the tissue, which in turn increases the thyroid weight (TBI). The follicular cell hyperplasia, hypertrophy, TBIs and colloid depletion as observed under microscope are tabulated (Table 3 ) which indicate fair to high antithyroid effects of the compounds. 
Conclusion
Derivatives of 2-(9H-purin-6-ylsulfanyl)acetohydrazide (3-11) possess notable antithyroid effects with some being more active than others. Very stable charge transfer complexation with iodine and significant hormonal variations in vivo suggests further study on these compounds from cytotoxic point of view, which may lead to the discovery of a new drug.
Experimental section Synthesis
Reagent grade materials were purchased from Aldrich Chemical Co. and were used without further purification. Melting points were determined using a Gallenkamp melting point apparatus and are uncorrected. 1 H NMR spectra were taken in DMSO-d 6 and recorded at 300, 400 and 500 MHz. 13 C NMR spectra were taken in 75 and 100 MHz on a Brucker/XWIN-NMR instrument. Chemical shifts are given in ppm relative to (Me) 4 Si as internal standard (abbreviations: s, singlet; d, doublet; t, triplet; m, multiplet). Mass spectra were recorded on JEOL MS Route. Elemental analyses were carried out on Perkin Elmer 2400-CHN Analyzer performed in H.E.J. Research Institute, Karachi University, Karachi and were within the range of ±0.4% of predicted values for all the compounds. UV/VIS Spectra were recorded on a double beam UVD-3500 spectrophotometer (Labomed Inc.). Modified House hold microwave system (900 watts) was used for microwave assisted synthesis. Thin Layer chromatography was carried out on Merck silica gel 60F 254 plates. Iodine was obtained from Merck (suprapur) bisublimed and was kept in dark in a dessicator containing P 2 O 5 . DMSO of spectroscopic grade was obtained from Merck, was dried over calcium hydride, distilled under reduced pressure and stored over type 4A 4 A molecular sieves. Radioimmunoassay (RIA) kits for free T 3 and T 4 were obtained from Immunotech (France) and TSH for rat ELISA kit from Cusabio Biotech Ltd. (China) and blood assay was carried out at Centre for Nuclear Medicine Lahore (Pakistan).
Ethyl (9H-purin-6-ylsulfanyl)acetate (1)
Conventional Method: 6-Sulfanylpurine monohydrate (0.170 g, 1 mmol), triethylamine (0.14 mL, 1 mmol) and ethyl chloroacetate (0.18 mL, 1.1 mmol) in ethanol (10 mL) was refluxed for six hours. Ethanol was removed under reduced pressure and the product was recrystallized from ethanol. Purity of all reported compounds is more than 95%.
Microwave Assisted Synthesis. 6-Sulfanylpurine monohydrate (0.170 g, 1 mmol), triethylamine (0.14 mL, 1 mmol) and ethyl chloroacetate (0.18 mL, 1.1 mmol) in ethanol (10 mL) were irradiated in modified household microwave oven (900 watts) equipped with water condenser for five minutes. The reaction was worked up as mentioned above.
Amorphous powder: mp 110 °C; Yield conventional 63%; microwave 91%; 1 H NMR δ (300 MHz, DMSO- 
2-(9H-purin-6-ylsulfanyl)acetohydrazide (2)
Conventional Method. Ethyl (9H-purin-6-ylsulfanyl)acetate (0.256 g, 1 mmol) and hydrazine hydrate (0.12 mL, 2.5 mmol) in ethanol (10 mL) were refluxed for five hours. Reaction was monitored by TLC. After the completion of reaction, solution was concentrated and refrigerated overnight. White precipitates obtained on cooling, were dried and recrystallized in ethanol.
Microwave Assisted Synthesis: Ethyl (9H-purin-6-ylsulfanyl)acetate (0.256 g, 1 mmol) and hydrazine hydrate (0.12 mL, 2.5 mmol) were dissolved in ethanol (10 mL). The reaction flask was irradiated in microwave oven for three minutes. Reaction was monitored by TLC, white precipitates obtained were dried and recrystallized in ethanol. 
N'-[Substituted Phenylmethylidene]-2-(9H-purin-6-ylsulfanyl) acetohydrazide (3-11)
General Procedure: A mixture of 2-(8,9-dihydro-7H-purin-6-ylsulfanyl)acetohydrazide (1 mmol) and substituted benzalde- hydes (1.1 mmol) in ethanol (20 mL) with few drops of acetic acid were refluxed for 4-6 hours. The progress of the reaction was monitored by TLC. The product obtained as precipitate was filtered hot and recrystallized from ethanol.
N'-[(E)-(4-Nitrophenyl)Methylidene]-2-(9H-purin-6-ylsulfanyl)acetohydrazide (3) N'-[(E)-(4-nitrophenyl)methylidene]-2-(9H-purin-6-ylsulfanyl
)acetohydrazide was prepared from 2-(9H-purin-6-ylsulfanyl) acetohydrazide (2) (0.226 g, 1 mmol) and 4-nitrobenzaldehyde (0.166 g, 1.1 mmol) in ethanol (20 mL) with a few drops of acetic acid. Immediate reaction took place and yellow precipitates of the product were obtained. 
N'-[(E)-(3-Nitrophenyl)Methylidene]-2-(9H-Purin-6-ylsulfany l)acetohydrazide (4) N'-[(E)-(3-nitrophenyl)methylidene]-2-(7H-purin-6-
N'-[(E)-(2-Nitrophenyl)methylidene]-2-(9H-Purin-6-ylsulfanyl)acetohydrazide (5) N'-[(E)-(2-nitrophenyl)methylidene]-2-(7H-purin-6ylsulfanyl)
acetohydrazide was prepared from 2 (0.226 g, 1 mmol) and 2-nitrobenzaldehyde (0.166 g, 1.1 mmol) in ethanol (20 mL) with a few drops of acetic acid.
Light 
2-(6,9-Dihydro-5H-purin-6-ylsulfanyl)-N'-[(E)-(2-methoxyphe nyl)methylidene]acetohydrazide (8)
2-(6,7-dihydro-5H-purin-6-ylsulfanyl)-N'-[(methoxyphenyl)m ethylidene]acetohydrazide was prepared from 2 (0.226 g, 1 mmol) and 3-methoxybenzaldehyde (0.149 g, 1.1 mmol) in ethanol (20 mL). 
2-(6,9 -Dihydro-5H-Purin-6-ylsulfanyl)-N'-[(E)-(2-hydroxyph enyl)methylidene]acetohydrazide (9)
2-(6,7-dihydro-5H-purin-6-ylsulfanyl)-N'-[(E)-(2-hydroxyphe nyl)methylidene]acetohydrazide was prepared from 2 (0.226 g, 1 mmol) and salicyaldehyde (0.134 g, 1.1 mmol) in ethanol (20 mL). 
